HIG Capital, a prominent global alternative investment firm, is making significant strides in the healthcare industry. With a strategic approach, the Miami-based firm is diversifying its portfolio through targeted acquisitions and sales, showcasing its commitment to growth in this dynamic sector.
In a notable move, HIG Capital acquired SkinCure Oncology, a leader in non-invasive cancer treatments. This acquisition aligns with HIG’s strategy to invest in innovative healthcare solutions, particularly those offering cutting-edge treatments like image-guided superficial radiation therapy. Such advancements cater to a growing need for non-invasive options for nonmelanoma skin cancer patients.
Meanwhile, HIG Capital successfully completed the sale of BIOVECTRA, marking another strategic shift. The company, specializing in active pharmaceutical ingredients and intermediates, was sold to Agilent Technologies. This transaction underscores HIG’s ability to nurture and grow its investments, having enhanced BIOVECTRA’s operations and market presence since its acquisition in 2019.
Beyond healthcare, HIG Capital is also expanding into adjacent sectors that support healthcare infrastructure. The acquisition of Action Elevator, a service provider for elevator maintenance and modernization, highlights this broadening of focus. By investing in essential services, HIG Capital is ensuring that critical infrastructure components, such as those in healthcare facilities, receive the necessary support and upgrades.
These strategic moves reflect HIG Capital’s commitment to identifying and maximizing opportunities in sectors with strong growth potential. As the firm continues to evolve its portfolio, its focus remains clear: investing in diverse industries that drive innovation and offer robust returns.
HIG Capital’s strategic initiatives in healthcare and related fields underscore its role as a pivotal player in transforming and advancing these industries.